ARCHIVES

Phase III Trial Data: Lenvatinib Extends PFS by Over 14 Months

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

Clinical Sciences Director Liu To Head Singapore Program.

January 12, 2001

Varmus, Branscomb Win Public Service Award From NSF; NCI Clarifies Plans For Large R01s

June 1, 2001

Natcher Subcommittee Open Door To justification for Increasing Cancer Program 1982 Appropriation

April 3, 1981

Immune Systems Don’t Stop, Causing Fatigue For Survivors

May 26, 2006

Groups Have No Budgets As NCTN Begins Work March 1

February 28, 2014

BioMedicines Begins Kidney Cancer Study; EntreMed Moves Forward.

February 25, 2000